Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 10 Myeloid 3 Tumor-Agnostic 2 Thoracic 2 Sarcoma 1 Lymphoid 1 Gynecologic 1

Conditions

Sarcoma, Myeloid 1 Leukemia, Myeloid, Acute 1

Interventions

Radiotherapy 221 Cyclophosphamide 211 Doxorubicin 210 Temozolomide 182 Ifosfamide 121 Filgrastim 111 Imatinib Mesylate 104 Etoposide 101 Vincristine 92 Gemcitabine 89 Bevacizumab 83 Magnetic Resonance Spectroscopy 81 Irinotecan 79 pembrolizumab 75 Radiation 70 Carboplatin 65 Methotrexate 62 pazopanib 61 Nivolumab 58 Cisplatin 58 fludarabine phosphate 57 Surgical Procedures, Operative 57 Peripheral Blood Stem Cell Transplantation 57 Specimen Handling 56 Trabectedin 52 Docetaxel 50 Biopsy 50 Busulfan 49 Melphalan 46 Paclitaxel 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

vosaroxin × Sarcoma × Clear all

NCT02658487 2025-04-15

VITAL

Vanderbilt-Ingram Cancer Center

Phase 2 Completed

42 enrolled 12 charts

Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡